Flagship Pioneering’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.3M | Hold |
25,001,856
| – | – | 25.42% | 2 |
|
|
2025
Q1 | $42M | Hold |
25,001,856
| – | – | 17.82% | 3 |
|
|
2024
Q4 | $40.8M | Hold |
25,001,856
| – | – | 12.19% | 3 |
|
|
2024
Q3 | $104M | Hold |
25,001,856
| – | – | 17.57% | 3 |
|
|
2024
Q2 | $137M | Hold |
25,001,856
| – | – | 16.19% | 2 |
|
|
2024
Q1 | $250M | Hold |
25,001,856
| – | – | 16.4% | 2 |
|
|
2023
Q4 | $102M | Hold |
25,001,856
| – | – | 7.7% | 2 |
|
|
2023
Q3 | $96.8M | Sell |
25,001,856
-8,288,162
| -25% | -$32.1M | 7.02% | 2 |
|
|
2023
Q2 | $198M | Sell |
33,290,018
-949,000
| -3% | -$5.66M | 8.85% | 2 |
|
|
2023
Q1 | $112M | Hold |
34,239,018
| – | – | 4.35% | 4 |
|
|
2022
Q4 | $135M | Hold |
34,239,018
| – | – | 4.32% | 3 |
|
|
2022
Q3 | $205M | Hold |
34,239,018
| – | – | 8.65% | 2 |
|
|
2022
Q2 | $220M | Hold |
34,239,018
| – | – | 8.29% | 2 |
|
|
2022
Q1 | $283M | Hold |
34,239,018
| – | – | 6.64% | 2 |
|
|
2021
Q4 | $530M | Hold |
34,239,018
| – | – | 8.19% | 2 |
|
|
2021
Q3 | $771M | Hold |
34,239,018
| – | – | 8.07% | 2 |
|
|
2021
Q2 | $673M | Hold |
34,239,018
| – | – | 8.6% | 3 |
|
|
2021
Q1 | $1.15B | Buy |
+34,239,018
| New | +$1.15B | 18.35% | 2 |
|